Targeting of Tumor Neovasculature with GrB/VEGF(121), a Novel Cytotoxic Fusion Protein

Angiogenesis is a critical process in numerous diseases, and intervention in neovascularization has therapeutic value in several disease settings, including ocular diseases, arthritis, and in tumor progression and metastatic spread. Various vascular targeting agents have been developed, including th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamedali, Khalid A., Rosenblum, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618300/
https://www.ncbi.nlm.nih.gov/pubmed/28714916
http://dx.doi.org/10.3390/biomedicines5030042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618300/
https://www.ncbi.nlm.nih.gov/pubmed/28714916
http://dx.doi.org/10.3390/biomedicines5030042

Ejemplares similares